Shockwave Medical, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019
Revenue:
Product revenue
Cost of revenue:
Cost of product revenue
Gross profit
Operating expenses:
Research and development
Sales and marketing
General and administrative
Total operating expenses
Income (loss) from operations
Loss from equity method investment
Interest expense
Change in fair value of warrant liability
Other income (expense), net
Net income (loss) before taxes
Income tax (benefit) provision
Net income (loss)
Unrealized gain (loss) on available-for-sale securities
Other comprehensive income (loss)
Unrealized gain (loss) on available-for-sale securities, net of tax
Adjustment for net gain realized and included in other income, net
Total comprehensive income (loss)
Net loss per share, basic and diluted
Shares used in computing net loss per share, basic and diluted
Net income (loss) per share
Basic (USD per share)
Diluted (USD per share)
Denominator:
Basic (in shares)
Diluted (in shares)

Comments